|Bid||65.67 x 900|
|Ask||65.70 x 800|
|Day's Range||65.12 - 66.43|
|52 Week Range||48.01 - 83.30|
|Beta (5Y Monthly)||0.84|
|PE Ratio (TTM)||22.91|
|Earnings Date||Oct 28, 2020|
|Forward Dividend & Yield||1.12 (1.72%)|
|Ex-Dividend Date||Sep 30, 2020|
|1y Target Est||85.86|
Encompass Health Corporation (NYSE: EHC) today announced the pricing of its underwritten public offering of $400 million in aggregate principal amount of its 4.625% senior notes due 2031 at a public offering price of 100% of the principal amount. The Company will pay interest on the notes semi-annually in arrears on April 1 and October 1 of each year, beginning on April 1, 2021. The notes will be jointly and severally guaranteed on a senior unsecured basis by all of its existing and future subsidiaries that guarantee borrowings under the Company's credit agreement and other capital markets debt. This offering is expected to close on October 5, subject to customary closing conditions.
Encompass Health Corporation (NYSE: EHC) today announced it has commenced a public offering of $400 million in aggregate principal amount of senior notes maturing in 2031. The Company intends to use the net proceeds from this offering, together with $300 million of cash on hand, to fully redeem its 5.75% Senior Notes due 2024 at par.
Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Encompass...